Telehealth provided temporary measures throughout the pandemic to access abortion by mail. In turn, abortion via telehealth widened access, breaking barriers such as affordability and offering a stigma-free experience.

Abortion through medication, which involves taking mifepristone and misoprostol, was first approved by the FDA in 2000. However, the FDA imposed restrictions on obtaining mifepristone in person.

The Biden administration paused this restriction, allowing patients to receive abortion pills by mail, telehealth or mail-order pharmacy throughout the pandemic. Whether this lift is temporary is up in the air. In some states, such as Texas, bills are being passed to ban mail-in abortion medication entirely.

A recent study found abortion medication by telehealth has a 95 percent efficacy rate (similar to in-person) and that it is both a feasible and safe option. The American College of Obstetricians and Gynecologists